Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial

G. Comi, N. De Stefano, M.S. Freedman, F. Barkhof, C.H. Polman, B.M.J. Uitdehaag, F. Casset-Semanaz, B. Hennessy, M.S. Moraga, S. Rocak, B. Stubinski, L. Kappos

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)33-41
JournalLancet Neurology
Volume11
Issue number1
DOIs
Publication statusPublished - 2012

Cite this